Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S1 Combined With Cisplatin in Recurrence/Metastasis of ESCC
NCT01854749Phase 2Completed
- Sponsor
- Fudan University
- Start
- Nov 2011
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tegafur + gimeracil + oteracil in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Fudan University. Primary endpoint: Progression-Free Survival. Started Nov 2011; status: completed.
02
Drugs
tegafur + gimeracil + oteracil
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT01854749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01854749.